Latest News about CYTK
Recent news which mentions CYTK
From Benzinga
 
   Gold Falls Sharply; US Composite PMI Surges In May
   
  
  
  May 23, 2024
  From Benzinga
 
   Why Cytokinetics (CYTK) Shares Are Falling
   
  
  
  May 23, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 Tickers 
   CYTK
  
  
  From InvestorPlace
 From InvestorPlace
 
   3 Biotech Stocks to Buy on the Dip: April 2024
   
  
  
  April 26, 2024
  From InvestorPlace
 From Benzinga
 
   2 Incredible Growth Stocks to Buy Right Now
   
  
  
  March 20, 2024
  From Motley Fool
 
   7 Biotech Stocks Ready to Ride the Sector’s Resurgence
   
  
  
  March 18, 2024
  From InvestorPlace
 From Benzinga
 
   7 Biotech Stocks to Buy as Sector Rotation Ramps Up
   
  
  
  March 13, 2024
  From InvestorPlace
 
   Unpacking the Latest Options Trading Trends in Cytokinetics
   
  February 28, 2024
  Tickers 
   CYTK
  
  
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For February 27, 2024
   
  
  
  February 27, 2024
  From Benzinga
 From Benzinga
 
   3 Biotech Stocks to Buy for the Next Bull Run: February 2024
   
  
  
  February 08, 2024
  From InvestorPlace
 
   Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session
   
  
  
  February 05, 2024
  From Benzinga
 From Benzinga
 
   3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
   
  
  
  January 26, 2024
  From InvestorPlace
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  January 15, 2024
  From Benzinga
 
   Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
   
  
  
  January 12, 2024
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.